Literature DB >> 25405599

The global contribution of outdoor air pollution to the incidence, prevalence, mortality and hospital admission for chronic obstructive pulmonary disease: a systematic review and meta-analysis.

Qingkun Song1, David C Christiani2, Jun Ren3.   

Abstract

OBJECTIVE: This study aimed to investigate the quantitative effects of outdoor air pollution, represented by 10 µg/m(3) increment of PM10, on chronic obstructive pulmonary disease in China, United States and European Union through systematic review and meta-analysis.
METHODS: Publications in English and Chinese from PubMed and EMBASE were selected. The Cochrane Review Handbook of Generic Inverse Variance was used to synthesize the pooled effects on incidence, prevalence, mortality and hospital admission.
RESULTS: Outdoor air pollution contributed to higher incidence and prevalence of COPD. Short-term exposure was associated with COPD mortality increased by 6%, 1% and 1% in the European Union, the United States and China, respectively (p < 0.05). Chronic PM exposure produced a 10% increase in mortality. In a short-term exposure to 10 µg/m(3) PM10 increment COPD mortality was elevated by 1% in China (p < 0.05) and hospital admission enrollment was increased by 1% in China, 2% in United States and 1% in European Union (p < 0.05).
CONCLUSIONS: Outdoor air pollution contributes to the increasing burdens of COPD.10 µg/m(3) increase of PM10 produced significant condition of COPD death and exacerbation in China, United States and European Union. Controlling air pollution will have substantial benefit to COPD morbidity and mortality.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25405599      PMCID: PMC4245645          DOI: 10.3390/ijerph111111822

Source DB:  PubMed          Journal:  Int J Environ Res Public Health        ISSN: 1660-4601            Impact factor:   3.390


1. Introduction

Chronic obstructive pulmonary disease (COPD) is one of the leading health burdens worldwide, accounting for 3.0 million deaths annually [1]. Up to 2010, COPD was still the leading cause of deaths, and among the top 5 causes for years of life lost in East and South Asia [2,3]. Globally there are 210 million people suffering from COPD [4]. Without effective intervention, the deaths from COPD will increase by more than 30% in the next decade [4]. The major risk factors of COPD includes tobacco smoking, outdoor air pollution and indoor air pollution from biomass fuel burning [4,5,6]. From some systematic reviews, exposing to indoor air pollution introduced a more than 2-fold risk of COPD, tobacco smoking definitely increased the risk of chronic respiratory diseases and smoking cessation was an effective strategy for COPD treatment [7,8,9,10]. However, the effects from outdoor air pollution on COPD burdens and exacerbation were seldom reported from systematic reviews. Reports of the efficacy of air control strategies on prevention of chronic pulmonary diseases were few. Recently, China faces a huge challenge in outdoor air pollution and chronic respiratory diseases become main issues threatening Chinese people’s health. Verifying the efficacy of air quality improvement on COPD burdens, especially significant reductions of particulate matter (PM), is meaningful to Chinese policymakers. This study aimed to quantitatively assess the contribution from outdoor air pollution to COPD burdens, in order to present a goal and evidence of improving air quality.

2. Experimental Section

2.1. Data Sources

Databases: PubMed and EMBASE were the target databases. PubMed was accessed through NCBI (from 1January 1980 to 31 March 2012) [11]. EMBASE was accessed via Harvard (from 1980 to 2012) [12]. We selected the publications investigating the effects of outdoor air pollution on COPD, in terms of incidence, prevalence, mortality and hospital admission.

2.2. Search Terms and Strategy to Select Articles

Search terms: Ambient air pollution Urban air pollution Outdoor air pollution COPD Chronic obstructive pulmonary disease Chronic bronchitis Emphysema In all fields search: “(1) AND (4)” OR “(1) AND (5)” OR “(1) AND (6)” OR “(1) AND (7)” OR “(2) AND (4)” OR “(2) AND (5)” OR “(2) AND (6)” OR “(2) AND (7)” OR “(3) AND (4)” OR “(3) AND (5)” OR “(3) AND (6)” OR “(3) AND (7)”.

2.3. Study Selection

COPD includes chronic bronchitis and emphysema [4]. For the complexity of outdoor air, PM was chosen as the indicator of outdoor air quality [13]. Inclusion criteria were definition of COPD (ICD-10:J41–44), language (Chinese and English), study design (cohort, case-control, cross-sectional and time-series), original reports, relative risk and 95% confidence interval (95%CI) of PM. The exclusion criteria were reanalysis of previous data, review and comments to related study.

2.4. Data Extraction and Quality Assessment

The items of publication year, study design, study field, subjects setting, exposure, outcome, effect size, and adjusted factors were all extracted.In case of the collinearity, the extracted effect estimate of PM did not adjust any other pollutants in outdoor air.PM was classified as total suspended particulates (TSP, particulates less than 40 μm in diameter), inhalable particulates (PM10, particulates less than 10 μm in diameter), coarse particulates (particulates less than 10 μm but higher than 2.5 μm in diameter), fine particulates (PM2.5, particulates less than 2.5 μm in diameter) and ultra-fine particulates (PM0.1, particulates less than 0.1 μm in diameter). Most studies investigated PM10, and it was set as the representative of PM. Study characteristics of eligible articles were exhibited for quality assessment.

2.5. Data Synthesis

Review Manager (RevMan) is The Cochrane Collaboration’s software for preparing and maintaining Cochrane reviews. We used 5.0 version to measure the pooled effect. “Generic Inverse Variance” method was recommended to synthesize data in non-randomized studies [14]. If any studies provided the effect estimate of subgroups, the pooled effect was estimated across subgroups: the procedure can be interpreted as a meta-analysis at the level of an individual study [14]. Most studies investigating the acute effect in 2 days after air quality change, so the average estimate in lag 0–2 day was estimated. In addition, RevMan 5 provided estimates of the heterogeneity. We used Chi2 to assess the heterogeneity that p-value of Chi2 < 0.05 indicated significant heterogeneity. The random analysis model was used for the significant heterogeneity and the fixed analysis model was introduced for non-significant heterogeneity [15]. Publication biases between studies were assessed by funnel plot.

3. Results

In total 351 articles were identified by titles and abstracts and 67 were further assessed in details. Finally 44 studies were included in the study (Supplemental Figure S1). The included studies were published after 1990s and most were time-series designs (Supplemental Table S1). Among the studies on mortality, the cohort and cross-sectional study assessed the chronic effect of PM, and the case crossover and time-series studies analyzed the acute effect of PM (less than 7-day exposure) (Supplemental Table S1). Though these studies had adjustments of confounding factors (Supplemental Table S1), the observatory design still introduced median risk of bias. And some publications defined COPD by the symptoms not the lab tests, which was possible to have a high risk of bias.

3.1. Outdoor Air Pollution to COPD Incidence

One cohort study in California showed a 1.33-fold high risk of incidence from a more than 200μg/m3 TSP exposure. A nested case-control study in Athens, found the risk increased to 1.37 from a quartile increase of black smoke exposure.

3.2. Outdoor Air Pollution to COPD Prevalence

Three studies investigated the contribution to prevalence. Exposing to high level PM, pooled prevalence risk was increased by 11%, and heterogeneity was not significant (Figure 1).
Figure 1

The effect of outdoor air pollution on COPD prevalence.

The effect of outdoor air pollution on COPD prevalence.

3.3. Outdoor Air Pollution to COPD Mortality

Fourteen studies investigated the contribution to mortality. A 3% higher risk was observed for COPD death but the heterogeneity was significant (Figure 2).
Figure 2

The effect of outdoor air pollution on COPD mortality.

In different study designs, cohort studies observed an 11% higher risk from long-term exposure to exacerbating outdoor air pollution and case crossover studies observed a 1% higher risk in short-term exposure for COPD death (Table 1). In various regions, the pooled risk was 1.07 in EU and 1.01 in China from higher PM exposure; the heterogeneity was non-significant (Table 1). Short-term exposing to 10µg/m3 increment of PM10 produced a 1% higher acute death in China (Table 1).
Table 1

Subgroup analysis for the contribution of outdoor air pollution to COPD mortality *.

CategoryStudy Characteristics (Number of Studies)Summary EstimateSummary EstimateI2
Study designCohort (2)1.111.07~1.150%#
Case crossover (3)1.011.00~1.0142%#
Ecological study (8)1.021.01~1.0357%
Cross sectional (1)1.091.06~1.12NA
Research fieldEU (4)1.071.04~1.110%#
US (4)1.031.00~1.0684%
China (4)1.011.00~1.013%#
others (2)1.061.02~1.1187%
PM sizePM10 (11)1.021.01~1.0476%
TSP (3)1.071.01~1.1379%
PM incrementPM10 10 ug/m3 increment (8)1.021.01~1.0376%
Others (6)1.081.04~1.1258%
The effect of 10 ug/m3 PM10 increment in different areasChina (3)1.011.00~1.010%#
US (3)1.031.00~1.0687%
EU (1)1.040.99~1.06NA
Others (1)1.041.02~1.06NA
Effect durationChronic effect (3)1.101.07~1.120%#
Acute effect (11)1.021.01~1.0359%
Acute effects in different areasChina (4)1.011.00~1.013%#
EU (3)1.061.02~1.110%#
US (3)1.011.01~1.0256%#

* The significance level for heterogeneity was 0.05; # non-significant.

The effect of outdoor air pollution on COPD mortality. Subgroup analysis for the contribution of outdoor air pollution to COPD mortality *. * The significance level for heterogeneity was 0.05; # non-significant. Based on exposure term, long-term exposure (chronic effect) resulted in a 10% increase for mortality and short-term exposure (acute effect) introduced the death increased by 1% higher in China, 6% higher in EU and 1% higher in US (Table 1). 75% studies in China and US analyzed the acute effect of 10 µg/m3 PM10 increase, in contrast with 25% studies in EU. The other studies in EU investigated the chronic effect and the acute effect of more than 20 µg/m3 PM10 increase.

3.4. Outdoor Air Pollution and Hospital Admission for COPD

From Figure 3, the included studies presented the acute effect of exposure and the total effect estimate of hospital admissions was 1.02 with 95% CI: 1.01–1.02. The subgroup analysis by study design, research fields and PM size did not reduce the heterogeneities; but short-term exposing to10 ug/m3 increment of PM10 led to the hospital admission increased by 1% in China, 2% in US and 1% in EU, and the heterogeneity was non-significant (Table 2).
Figure 3

The effect of outdoor air pollution on COPD hospital admission.

Table 2

Subgroup analysis for the contribution of outdoor air pollution to hospital admission for COPD *.

CategoryStudy Characteristics (Number of Studies)Summary EstimateSummary EstimateI2
Study DesignCase-crossover (4)1.111.00 ~ 1.2384%
Ecological study (23)1.021.01 ~ 1.0264%
Research FieldUS (10)1.021.01 ~ 1.0371%
EU (8)1.021.01 ~ 1.0461%
China (5)1.011.01 ~ 1.0280%
Others (4)1.051.02 ~ 1.0846% #
PM sizePM10 (19)1.021.01 ~ 1.0272%
Others (8)1.021.01 ~ 1.0360%
PM incrementPM10 10 ug/m3 increment (9)1.011.01 ~ 1.0116% #
Others (18)1.031.02 ~ 1.0575%
The effect of 10 ug/m3 PM10 increment in different areaschina (3)1.011.01 ~ 1.0146% #
US (4)1.021.01 ~ 1.030% #
EU (2)1.011.00 ~ 1.0259% #

* The significant level for heterogeneity was 0.05; # non-significant.

The effect of outdoor air pollution on COPD hospital admission.

3.5. Publication Bias

The publication bias was tested by funnel plots among the time-series studies about mortality and all the studies about hospital admission (Supplemental Figures S2 and S3). For mortality, the missing studies appeared in areas of 0.05 < p < 0.10; for hospital admission, the supposed missing studies were in area of p < 0.05. And when we funnel plotted the studies about hospital admission of 10 μg/m3 increase of PM10, almost all study plots were on the effect estimate line. Most missing studies were in the significant level, so the asymmetry of funnel plots was probably not caused by publication bias. Subgroup analysis for the contribution of outdoor air pollution to hospital admission for COPD *. * The significant level for heterogeneity was 0.05; # non-significant.

4. Discussion

Smoking and indoor air pollution introduced increasing risk to COPD. In this study, PM exposures from outdoor air pollution definitively increased COPD burdens. Ten μg/m3 increase of PM10 was related with higher risk of COPD death and hospital admission. PM exposure could induce biological changes in respiratory system. PM suspensions increased airway hyper-responsiveness to acetylcholine and reduced host defense in rodents; the exposure released neutrophil influx, bronchoalveolar lavage protein and cytokine in lung tissues [16]. Ambient air particles could induce the production of reactive oxygen and inflammatory factors in alveolar macrophages [17,18,19], polymorphonuclear granulocytes [20] and bronchial epithelial cells [21]. The reactive oxygen species, inflammatory factor production and respiratory inflammation, played important roles in lung tissue injury and higher risk of COPD. The relative risk for incidence was observed higher than prevalence. The studies on COPD incidence investigated TSP of higher than 200μg/m3 [22] and black smoke of more than 10 μg/m3 increase [23] but the studies on COPD prevalence analyzed PM2.5 of 1 μg/m3 increase [24] and TSP of 10 μg/m3 increase [25]. Higher exposure might introduce a higher effect. Additionally, PM increase in outdoor air pollution was associated with a higher risk of death, and the severe cases might die due to the exposure and old age. Therefore, a lower effect estimate was observed in prevalent cases than incident cases. The stronger contribution to prevalence in China than Western countries is likely related to the severe air quality in China [26]. The acute effect of mortality was a little higher in EU than US and China, which was the result of different exposure characteristics: the studies in China and US analyzed the effect of lower level exposure than the studies in EU. The chronic effect of outdoor air pollution on COPD mortality was much more severe than acute effect, because of longer exposure time.The increase of hospital admission for COPD after the outdoor air pollution rise suggested that outdoor air pollution affected the exacerbation of COPD status. When a funnel plot was used to detect the publication bias in this analysis, it seemed that the plots were somewhat visually asymmetrical. The asymmetry indicated there were small-study effects in the analysis [14]. Though some statistical methods were recommended by the Cochrane center for testing the asymmetry of funnel plot, the methods had relatively low power and were recommended in randomized control trials [14]. Therefore, we chose contour enhanced funnel plot to test the publication bias [14]. For the missing studies in significant areas, the asymmetry of funnel plot might not be the result of publication bias, but the heterogeneity and the artefactual: the association between effect estimate and standard error [14]. The inclusion of non-randomized studies was the primary limitation in this study. The Handbook Review of Cochrane still provided analytical methods for non-randomized studies. As suggested from Cochrane, generic inverse variation was selected to synthesize the data from non-randomized studies and the study characteristics were presented [14]. In contrast to randomized control trials, confounding bias was one of the key issues in non-randomized studies. The primary risk factors for COPD were tobacco smoking, indoor air pollution (such as biomass fuels), outdoor air pollution and occupational dusts and chemicals [4], and most of the included studies controlled these risk factors. Two cohorts failed to control the effects of tobacco smoking, but smoking appeared not to act as a confounder in analyses [27,28]. The case crossover and time series studies analyzed the acute effects of outdoor air pollution on COPD and in such a short term, smoking habit and biomass fuel usage were not possible to change seriously. Misclassification of exposure and outcome was another possible limitation in this analysis. In the included studies, the data of exposure to PM was provided by the government environmental department, who monitored the outdoor air quality and the diagnosis of COPD was defined in hospitals. The non-random design and potential risk of bias introduced the limitation in this study.

5. Conclusions

High level outdoor air pollution was associated with an increase of COPD incidence and prevalence. A 10 μg/m3 increase of PM10 in outdoor air can induce significant acute exacerbations and mortality in COPD. This study provides evidence for the need for air quality improvement and continual assessment. It is time to take action to improve air quality.
  19 in total

Review 1.  COPD and chronic bronchitis risk of indoor air pollution from solid fuel: a systematic review and meta-analysis.

Authors:  Om P Kurmi; Sean Semple; Padam Simkhada; W Cairns S Smith; Jon G Ayres
Journal:  Thorax       Date:  2010-03       Impact factor: 9.139

2.  Relation between concentration of air pollution and cause-specific mortality: four-year exposures to nitrogen dioxide and particulate matter pollutants in 470 neighborhoods in Oslo, Norway.

Authors:  Øyvind Naess; Per Nafstad; Geir Aamodt; Bjørgulf Claussen; Pål Rosland
Journal:  Am J Epidemiol       Date:  2006-11-29       Impact factor: 4.897

Review 3.  Ambient air pollution: a cause of COPD?

Authors:  Tamara Schikowski; Inga C Mills; H Ross Anderson; Aaron Cohen; Anna Hansell; Francine Kauffmann; Ursula Krämer; Alessandro Marcon; Laura Perez; Jordi Sunyer; Nicole Probst-Hensch; Nino Künzli
Journal:  Eur Respir J       Date:  2013-03-07       Impact factor: 16.671

4.  Regulation of macrophage inflammatory protein-2 gene expression by oxidative stress in rat alveolar macrophages.

Authors:  M M Shi; I Chong; J J Godleski; J D Paulauskis
Journal:  Immunology       Date:  1999-06       Impact factor: 7.397

5.  Air pollution in relation to manifestations of chronic pulmonary disease: a nested case-control study in Athens, Greece.

Authors:  A Karakatsani; S Andreadaki; K Katsouyanni; I Dimitroulis; D Trichopoulos; V Benetou; A Trichopoulou
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082

Review 6.  An official American Thoracic Society public policy statement: Novel risk factors and the global burden of chronic obstructive pulmonary disease.

Authors:  Mark D Eisner; Nicholas Anthonisen; David Coultas; Nino Kuenzli; Rogelio Perez-Padilla; Dirkje Postma; Isabelle Romieu; Edwin K Silverman; John R Balmes
Journal:  Am J Respir Crit Care Med       Date:  2010-09-01       Impact factor: 21.405

7.  A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990-2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Stephen S Lim; Theo Vos; Abraham D Flaxman; Goodarz Danaei; Kenji Shibuya; Heather Adair-Rohani; Markus Amann; H Ross Anderson; Kathryn G Andrews; Martin Aryee; Charles Atkinson; Loraine J Bacchus; Adil N Bahalim; Kalpana Balakrishnan; John Balmes; Suzanne Barker-Collo; Amanda Baxter; Michelle L Bell; Jed D Blore; Fiona Blyth; Carissa Bonner; Guilherme Borges; Rupert Bourne; Michel Boussinesq; Michael Brauer; Peter Brooks; Nigel G Bruce; Bert Brunekreef; Claire Bryan-Hancock; Chiara Bucello; Rachelle Buchbinder; Fiona Bull; Richard T Burnett; Tim E Byers; Bianca Calabria; Jonathan Carapetis; Emily Carnahan; Zoe Chafe; Fiona Charlson; Honglei Chen; Jian Shen Chen; Andrew Tai-Ann Cheng; Jennifer Christine Child; Aaron Cohen; K Ellicott Colson; Benjamin C Cowie; Sarah Darby; Susan Darling; Adrian Davis; Louisa Degenhardt; Frank Dentener; Don C Des Jarlais; Karen Devries; Mukesh Dherani; Eric L Ding; E Ray Dorsey; Tim Driscoll; Karen Edmond; Suad Eltahir Ali; Rebecca E Engell; Patricia J Erwin; Saman Fahimi; Gail Falder; Farshad Farzadfar; Alize Ferrari; Mariel M Finucane; Seth Flaxman; Francis Gerry R Fowkes; Greg Freedman; Michael K Freeman; Emmanuela Gakidou; Santu Ghosh; Edward Giovannucci; Gerhard Gmel; Kathryn Graham; Rebecca Grainger; Bridget Grant; David Gunnell; Hialy R Gutierrez; Wayne Hall; Hans W Hoek; Anthony Hogan; H Dean Hosgood; Damian Hoy; Howard Hu; Bryan J Hubbell; Sally J Hutchings; Sydney E Ibeanusi; Gemma L Jacklyn; Rashmi Jasrasaria; Jost B Jonas; Haidong Kan; John A Kanis; Nicholas Kassebaum; Norito Kawakami; Young-Ho Khang; Shahab Khatibzadeh; Jon-Paul Khoo; Cindy Kok; Francine Laden; Ratilal Lalloo; Qing Lan; Tim Lathlean; Janet L Leasher; James Leigh; Yang Li; John Kent Lin; Steven E Lipshultz; Stephanie London; Rafael Lozano; Yuan Lu; Joelle Mak; Reza Malekzadeh; Leslie Mallinger; Wagner Marcenes; Lyn March; Robin Marks; Randall Martin; Paul McGale; John McGrath; Sumi Mehta; George A Mensah; Tony R Merriman; Renata Micha; Catherine Michaud; Vinod Mishra; Khayriyyah Mohd Hanafiah; Ali A Mokdad; Lidia Morawska; Dariush Mozaffarian; Tasha Murphy; Mohsen Naghavi; Bruce Neal; Paul K Nelson; Joan Miquel Nolla; Rosana Norman; Casey Olives; Saad B Omer; Jessica Orchard; Richard Osborne; Bart Ostro; Andrew Page; Kiran D Pandey; Charles D H Parry; Erin Passmore; Jayadeep Patra; Neil Pearce; Pamela M Pelizzari; Max Petzold; Michael R Phillips; Dan Pope; C Arden Pope; John Powles; Mayuree Rao; Homie Razavi; Eva A Rehfuess; Jürgen T Rehm; Beate Ritz; Frederick P Rivara; Thomas Roberts; Carolyn Robinson; Jose A Rodriguez-Portales; Isabelle Romieu; Robin Room; Lisa C Rosenfeld; Ananya Roy; Lesley Rushton; Joshua A Salomon; Uchechukwu Sampson; Lidia Sanchez-Riera; Ella Sanman; Amir Sapkota; Soraya Seedat; Peilin Shi; Kevin Shield; Rupak Shivakoti; Gitanjali M Singh; David A Sleet; Emma Smith; Kirk R Smith; Nicolas J C Stapelberg; Kyle Steenland; Heidi Stöckl; Lars Jacob Stovner; Kurt Straif; Lahn Straney; George D Thurston; Jimmy H Tran; Rita Van Dingenen; Aaron van Donkelaar; J Lennert Veerman; Lakshmi Vijayakumar; Robert Weintraub; Myrna M Weissman; Richard A White; Harvey Whiteford; Steven T Wiersma; James D Wilkinson; Hywel C Williams; Warwick Williams; Nicholas Wilson; Anthony D Woolf; Paul Yip; Jan M Zielinski; Alan D Lopez; Christopher J L Murray; Majid Ezzati; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

Review 8.  Smoking cessation for chronic obstructive pulmonary disease.

Authors:  R M van der Meer; E J Wagena; R W J G Ostelo; J E Jacobs; C P van Schayck
Journal:  Cochrane Database Syst Rev       Date:  2003

Review 9.  Tobacco smoke, indoor air pollution and tuberculosis: a systematic review and meta-analysis.

Authors:  Hsien-Ho Lin; Majid Ezzati; Megan Murray
Journal:  PLoS Med       Date:  2007-01       Impact factor: 11.069

10.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010.

Authors:  Rafael Lozano; Mohsen Naghavi; Kyle Foreman; Stephen Lim; Kenji Shibuya; Victor Aboyans; Jerry Abraham; Timothy Adair; Rakesh Aggarwal; Stephanie Y Ahn; Miriam Alvarado; H Ross Anderson; Laurie M Anderson; Kathryn G Andrews; Charles Atkinson; Larry M Baddour; Suzanne Barker-Collo; David H Bartels; Michelle L Bell; Emelia J Benjamin; Derrick Bennett; Kavi Bhalla; Boris Bikbov; Aref Bin Abdulhak; Gretchen Birbeck; Fiona Blyth; Ian Bolliger; Soufiane Boufous; Chiara Bucello; Michael Burch; Peter Burney; Jonathan Carapetis; Honglei Chen; David Chou; Sumeet S Chugh; Luc E Coffeng; Steven D Colan; Samantha Colquhoun; K Ellicott Colson; John Condon; Myles D Connor; Leslie T Cooper; Matthew Corriere; Monica Cortinovis; Karen Courville de Vaccaro; William Couser; Benjamin C Cowie; Michael H Criqui; Marita Cross; Kaustubh C Dabhadkar; Nabila Dahodwala; Diego De Leo; Louisa Degenhardt; Allyne Delossantos; Julie Denenberg; Don C Des Jarlais; Samath D Dharmaratne; E Ray Dorsey; Tim Driscoll; Herbert Duber; Beth Ebel; Patricia J Erwin; Patricia Espindola; Majid Ezzati; Valery Feigin; Abraham D Flaxman; Mohammad H Forouzanfar; Francis Gerry R Fowkes; Richard Franklin; Marlene Fransen; Michael K Freeman; Sherine E Gabriel; Emmanuela Gakidou; Flavio Gaspari; Richard F Gillum; Diego Gonzalez-Medina; Yara A Halasa; Diana Haring; James E Harrison; Rasmus Havmoeller; Roderick J Hay; Bruno Hoen; Peter J Hotez; Damian Hoy; Kathryn H Jacobsen; Spencer L James; Rashmi Jasrasaria; Sudha Jayaraman; Nicole Johns; Ganesan Karthikeyan; Nicholas Kassebaum; Andre Keren; Jon-Paul Khoo; Lisa Marie Knowlton; Olive Kobusingye; Adofo Koranteng; Rita Krishnamurthi; Michael Lipnick; Steven E Lipshultz; Summer Lockett Ohno; Jacqueline Mabweijano; Michael F MacIntyre; Leslie Mallinger; Lyn March; Guy B Marks; Robin Marks; Akira Matsumori; Richard Matzopoulos; Bongani M Mayosi; John H McAnulty; Mary M McDermott; John McGrath; George A Mensah; Tony R Merriman; Catherine Michaud; Matthew Miller; Ted R Miller; Charles Mock; Ana Olga Mocumbi; Ali A Mokdad; Andrew Moran; Kim Mulholland; M Nathan Nair; Luigi Naldi; K M Venkat Narayan; Kiumarss Nasseri; Paul Norman; Martin O'Donnell; Saad B Omer; Katrina Ortblad; Richard Osborne; Doruk Ozgediz; Bishnu Pahari; Jeyaraj Durai Pandian; Andrea Panozo Rivero; Rogelio Perez Padilla; Fernando Perez-Ruiz; Norberto Perico; David Phillips; Kelsey Pierce; C Arden Pope; Esteban Porrini; Farshad Pourmalek; Murugesan Raju; Dharani Ranganathan; Jürgen T Rehm; David B Rein; Guiseppe Remuzzi; Frederick P Rivara; Thomas Roberts; Felipe Rodriguez De León; Lisa C Rosenfeld; Lesley Rushton; Ralph L Sacco; Joshua A Salomon; Uchechukwu Sampson; Ella Sanman; David C Schwebel; Maria Segui-Gomez; Donald S Shepard; David Singh; Jessica Singleton; Karen Sliwa; Emma Smith; Andrew Steer; Jennifer A Taylor; Bernadette Thomas; Imad M Tleyjeh; Jeffrey A Towbin; Thomas Truelsen; Eduardo A Undurraga; N Venketasubramanian; Lakshmi Vijayakumar; Theo Vos; Gregory R Wagner; Mengru Wang; Wenzhi Wang; Kerrianne Watt; Martin A Weinstock; Robert Weintraub; James D Wilkinson; Anthony D Woolf; Sarah Wulf; Pon-Hsiu Yeh; Paul Yip; Azadeh Zabetian; Zhi-Jie Zheng; Alan D Lopez; Christopher J L Murray; Mohammad A AlMazroa; Ziad A Memish
Journal:  Lancet       Date:  2012-12-15       Impact factor: 79.321

View more
  56 in total

1.  Invited Commentary: The Power of Preterm Birth to Motivate a Cleaner Environment.

Authors:  Pauline Mendola
Journal:  Am J Epidemiol       Date:  2018-08-01       Impact factor: 4.897

2.  Does the Hospital Admission of Patients with Respiratory Disease Increase in Izmir When the PM10 Level is High?

Authors:  Enver Yalnız; Özgür Uslu; Erkut Bolat; Sedat Altın; Gülru Polat
Journal:  Turk Thorac J       Date:  2020-01-01

3.  A comprehensive evaluation of the association between ambient air pollution and adverse health outcomes of major organ systems: a systematic review with a worldwide approach.

Authors:  Jafar Bazyar; Negar Pourvakhshoori; Hamidreza Khankeh; Mehrdad Farrokhi; Vahid Delshad; Elham Rajabi
Journal:  Environ Sci Pollut Res Int       Date:  2019-03-22       Impact factor: 4.223

4.  Air Pollution - Who Is at Risk?

Authors:  Pauline Mendola
Journal:  Paediatr Perinat Epidemiol       Date:  2017-08-25       Impact factor: 3.980

5.  A joint ERS/ATS policy statement: what constitutes an adverse health effect of air pollution? An analytical framework.

Authors:  George D Thurston; Howard Kipen; Isabella Annesi-Maesano; John Balmes; Robert D Brook; Kevin Cromar; Sara De Matteis; Francesco Forastiere; Bertil Forsberg; Mark W Frampton; Jonathan Grigg; Dick Heederik; Frank J Kelly; Nino Kuenzli; Robert Laumbach; Annette Peters; Sanjay T Rajagopalan; David Rich; Beate Ritz; Jonathan M Samet; Thomas Sandstrom; Torben Sigsgaard; Jordi Sunyer; Bert Brunekreef
Journal:  Eur Respir J       Date:  2017-01-11       Impact factor: 16.671

6.  Global Association of Air Pollution and Cardiorespiratory Diseases: A Systematic Review, Meta-Analysis, and Investigation of Modifier Variables.

Authors:  Weeberb J Requia; Matthew D Adams; Altaf Arain; Stefania Papatheodorou; Petros Koutrakis; Moataz Mahmoud
Journal:  Am J Public Health       Date:  2017-10-26       Impact factor: 9.308

Review 7.  Air Pollution and Noncommunicable Diseases: A Review by the Forum of International Respiratory Societies' Environmental Committee, Part 2: Air Pollution and Organ Systems.

Authors:  Dean E Schraufnagel; John R Balmes; Clayton T Cowl; Sara De Matteis; Soon-Hee Jung; Kevin Mortimer; Rogelio Perez-Padilla; Mary B Rice; Horacio Riojas-Rodriguez; Akshay Sood; George D Thurston; Teresa To; Anessa Vanker; Donald J Wuebbles
Journal:  Chest       Date:  2018-11-09       Impact factor: 9.410

Review 8.  The Effects of Air Pollution and Temperature on COPD.

Authors:  Nadia N Hansel; Meredith C McCormack; Victor Kim
Journal:  COPD       Date:  2015-12-18       Impact factor: 2.409

9.  Biomarkers Predictive of Exacerbations in the SPIROMICS and COPDGene Cohorts.

Authors:  Jason D Keene; Sean Jacobson; Katerina Kechris; Gregory L Kinney; Marilyn G Foreman; Claire M Doerschuk; Barry J Make; Jeffrey L Curtis; Stephen I Rennard; R Graham Barr; Eugene R Bleecker; Richard E Kanner; Eric C Kleerup; Nadia N Hansel; Prescott G Woodruff; MeiLan K Han; Robert Paine; Fernando J Martinez; Russell P Bowler; Wanda K O'Neal
Journal:  Am J Respir Crit Care Med       Date:  2017-02-15       Impact factor: 21.405

10.  Exposure assessment of particulate matter and blood chromium levels in people living near a cement plant.

Authors:  Sung Ho Hwang; Jae Bum Park; Kyung Jong Lee
Journal:  Environ Geochem Health       Date:  2017-11-21       Impact factor: 4.609

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.